Breakthrough in CRISPR: HKUST scientists engineered a DNA-guided Cas12a system that targets and cleaves RNA with unprecedented precision. Practical advantages: DNA guides are cheaper, more stable, and ...

From studying microRNAs in embryonic stem cells to exploring exosomes in anti-tumor immunity, Blelloch illustrates how ...

This new research, published in the Genes & Diseases journal by a team from Chongqing Medical University and Southwest Medical University, investigated the precise mechanisms by which the long ...

Doctoral Student Coauthored Research That Could Transform Cancer Treatment As a doctoral student at Rutgers-Newark, Maciej ...

Johns Hopkins researchers have shown that disrupting energy metabolism in tumor cells can slow the growth of group 3 medulloblastoma, a highly aggressive pediatric brain cancer, in mice. The study ...

Cellular homeostasis and stress response are tightly coordinated processes involving a complex interplay between signaling ...

Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new layer of genetic regulation that could reshape how certain cancers are ...

People between the ages of 15 and 39 have especially unstable access to health coverage in the U.S. Young people in this age group are often finishing school or starting new jobs, including positions ...

WEST LAFAYETTE, Ind. — Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to grow and spread, a substantial advantage over even ...

Learn how messenger RNA, spike protein, and lipid nanoparticles drive rapid advances in vaccines and cancer therapies, reshaping modern medicine with precision and speed. Pixabay, spencerbdavis1 ...

NEWARK, DE / ACCESS Newswire / March 23, 2026 / According to Future Market Insights (FMI), the global self-amplifying RNA (saRNA) cancer immunotherapy platforms market is entering a high-growth phase ...

Abstract: Drug resistance is a common problem in both hormone receptor-positive and triple-negative breast cancers, posing significant challenges in effective treatment. Palbociclib, a CDK4/6 ...